Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene

B Weinhold, U Rüther, B Weinhold, U Rüther

Abstract

We have investigated the function of different mediators of the regulation of the human C-reactive protein (hCRP) gene in transgenic mice. hCRP was induced by lipopolysaccharide and wounding in interleukin-6 (IL-6) +/+ mice, but not in IL-6 -/- mice. This finding suggested that IL-6 is necessary for the induction of hCRP. However, injection of IL-6 did not induce the hCRP gene. Thus, the induction of hCRP by IL-6 seems to require an additional cofactor. Therefore, we screened different cytokines for their activity in IL-6 +/+ and IL-6 -/- mice. Surprisingly, interleukin-1beta, as well as oncostatin M or leukaemia inhibitory factor, led to an induction of hCRP in both genetic backgrounds. These results indicate an IL-6-dependent and -independent regulation of hCRP. These hCRP transgenic mice therefore represent a novel model system for defining the cytokine network involved in the regulation of acute-phase genes during the course of inflammation.

References

    1. Clin Chim Acta. 1981 Nov 25;117(1):13-23
    1. Biochem J. 1997 Aug 1;325 ( Pt 3):617-21
    1. Anal Biochem. 1987 Apr;162(1):156-9
    1. EMBO J. 1987 Dec 20;6(13):4017-22
    1. Nucleic Acids Res. 1988 Apr 25;16(8):3195-207
    1. Eur J Immunol. 1988 May;18(5):717-21
    1. Eur J Immunol. 1988 Aug;18(8):1259-64
    1. Biochem Biophys Res Commun. 1988 Nov 30;157(1):271-7
    1. Lymphokine Res. 1988 Winter;7(4):403-12
    1. J Immunol. 1989 Feb 1;142(3):808-12
    1. FEBS Lett. 1989 Jan 2;242(2):237-9
    1. EMBO J. 1989 Dec 1;8(12):3773-9
    1. Biochem J. 1990 Feb 1;265(3):621-36
    1. EMBO J. 1990 Jun;9(6):1897-906
    1. J Biol Chem. 1991 Aug 5;266(22):14147-50
    1. J Biol Chem. 1991 Oct 25;266(30):20424-7
    1. Arch Surg. 1992 Jan;127(1):31-6; discussion 36-7
    1. J Immunol. 1992 Mar 1;148(5):1486-92
    1. J Immunol. 1992 Mar 15;148(6):1731-6
    1. Blood. 1993 Jun 15;81(12):3226-33
    1. Science. 1994 Jan 7;263(5143):89-92
    1. Science. 1994 Jan 7;263(5143):92-5
    1. Nature. 1994 Mar 24;368(6469):339-42
    1. EMBO J. 1994 Mar 1;13(5):1189-96
    1. Immunol Today. 1994 Feb;15(2):74-80
    1. Immunol Today. 1994 Feb;15(2):81-8
    1. J Exp Med. 1994 Oct 1;180(4):1243-50
    1. Mol Cell Biol. 1994 Oct;14(10):6561-9
    1. J Exp Med. 1979 Sep 19;150(3):597-606
    1. Br Heart J. 1982 Mar;47(3):239-43
    1. J Biol Chem. 1995 Jan 13;270(2):704-8
    1. Cell. 1995 Feb 10;80(3):401-11
    1. Eur J Immunol. 1995 Dec;25(12):3474-81
    1. Cell. 1996 Feb 9;84(3):331-4
    1. Cell. 1996 Feb 9;84(3):431-42
    1. Cell. 1996 Feb 9;84(3):443-50
    1. J Biol Chem. 1996 Apr 19;271(16):9503-9
    1. Blood. 1996 Mar 1;87(5):1851-4
    1. Development. 1996 Apr;122(4):1235-42
    1. J Biol Chem. 1996 Jun 21;271(25):14764-72
    1. J Mol Med (Berl). 1996 Jan;74(1):1-12
    1. Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11008-13
    1. Adv Immunol. 1983;34:141-212

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere